BackAlaunos Therapeutics Overview

Alaunos Therapeutics Current Cash

Latest current cash for TCRT: $350K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$354000.00
10.97% YoYΔ $35000.00 vs prior year quarter

Peer average / median

Loading

Alaunos Therapeutics Current Cash History

Loading

Alaunos Therapeutics vs. peers: Current Cash Comparison

Loading

Alaunos Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alaunos Therapeutics (TCRT) FAQ

As of the most recent data (March 2026), TCRT shows a current cash of $350K. That compares with $320K in the prior-year period — up 11.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TCRT's current cash is now $350K (was $320K) — a 11.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Alaunos Therapeutics is outperforming or lagging.

Tracking TCRT's current cash over time shows whether Alaunos Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $350K That compares with $320K in the prior-year period — up 11.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Alaunos Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $350K) with ownership activity and broader fundamentals.

Alaunos Therapeutics's current cash is $350K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.